Barriers and carriers for non-viral delivery of mRNA to induce transient protein expression in the retina: the hurdles of the inner limiting membrane and innate immunity versus the potential of mRNA self-amplification.

Barriers and carriers for non-viral delivery of mRNA to induce transient protein expression in the retina: the hurdles of the inner limiting membrane and innate immunity versus the potential of mRNA self-amplification.

Genetic therapy for EYS- and USH2A-associated retinal dystrophy ("GET-READY")

High pressure intraperitoneal aerosolization of chemotherapeutics, nanoparticles and hydrogels to treat peritoneal carcinomatosis: effect on tumor penetration, biodistribution and anti-cancer activity.

ILM photodisruption: a biophotonic approach to promote retinal ganglion cell engraftment as a cure for blindness

Intraperitoneal Drug Delivery for Peritoneal Carcinomatosis: from Bench to Bedside

Intraperitoneal nebulization of thermosensitive hydrogels for the controlled release of chemotherapeutics and biopharmaceuticals to treat peritoneal carcinomatosis

Let There Be Light: two biophotonic approaches to boost retinal ganglion cell transplantation as a cure for blindness

Nanoparticle formulations of toll-like receptor agonists and oxaliplatin for local intraperitoneal delivery to treat colorectal peritoneal metastasis

OVDS Sean Mc Cafferty: Drug-controllable protein expression forOVOS Sean Mc Cafferty: Drug-controllable protein expression form IL-12 encoding modified mRNA.

Photoporation of the inner limiting membrane to enhance retinal drug delivery after intravitreal injection

Postdoctoral Fellowship Program in National Glaucoma Research: "“Exploring ICG-mediated ILM photodisruption as a tool to boost retinal ganglion cell engraftment"

Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases

The barrier role of the vitreoretinal interface toward intravitreal injected proteins, viruses and siRNA nanoparticles: ex vivo bovine screening models and siRNA nanoparticle design.

Design of a novel antisense oligonucleotide therapy for inherited blindness

Design of a novel antisense oligonucleotide therapy for inherited blindness

Flow cytometer

Fluorescence correlation spectroscopy

Intraperitoneal Drug Delivery for Peritoneal Carcinomatosis: from Bench to Bedside

Intraperitoneal gene delivery of to prevent the formation and growth of peritoneal metastases: nanoparticle optimization and development of a thermosensitive hydrogel

Laser bench for laser scanning confocal microscopy

Nucleophilic Nanoparticles for optimal delivery of plasmid DNA in dividing cells.

Nucleophilic Nanoparticles for optimal delivery of plasmid DNA in dividing cells

INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES

Precision medicine in inherited blindness using integrated omics in human and animal models